Biotechnology News

July 24, 2012

OKLAHOMA CITY--(BUSINESS WIRE)--SensiQ Technologies, Inc. has been acquired by private equity firm TechVen Partners, and will seek to aggressively expand the market reach of its Label-Free SPR.

July 24, 2012

WASHINGTON--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced two-year Phase 3 clinical trial results showing that the integrase inhibitor elvitegravir dosed once daily is non-inferior to raltegravir dosed twice daily among...

July 24, 2012

WASHINGTON--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced 24-week data from a Phase 3 clinical trial, SPIRIT (Switching boosted PI to Rilpivirine In Combination with Truvada as a Single Tablet Regimen), which evaluated...

July 24, 2012

WASHINGTON--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced full clinical trial results from a pivotal Phase 3 study evaluating cobicistat, a pharmacoenhancing or “boosting” agent for HIV therapy, compared to ritonavir, which...

July 24, 2012

GRAND RAPIDS, Mich.--(BUSINESS WIRE)--The 2012 Transplant Games of America are quickly approaching and Spectrum Health employees are working in force to assist the West Michigan Sports Commission (WMSC) in hosting a successful event. Events take...

July 24, 2012

BERWYN, Pa.--(BUSINESS WIRE)--QR Pharma, Inc. is initiating the first human clinical trial of bisnorcymserine, its compound to treat advanced Alzheimer's disease, to evaluate safety and tolerability in elderly healthy volunteers

July 24, 2012

PARSIPPANY, N.J.--(BUSINESS WIRE)--IMS Health plans to post for note holders its second-quarter 2012 financial results on Monday, July 30, 2012. The company will conduct a conference call for IMS’s note holders to review these results at 1:00 p.m...

July 24, 2012

NASHUA, N.H.--(BUSINESS WIRE)--iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, announced today the availability of...

July 24, 2012

NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics Inc. (OTC:BCLI), a leading developer of adult stem cell technologies and therapeutics, announced today that its senior management will hold a conference call on...

July 24, 2012

MAYNARD, Mass.--(BUSINESS WIRE)--Allegro Diagnostics announced the completion of enrollment into the 1320-patient AEGIS II clinical trial, evaluating the diagnostic ability of BronchoGen to detect early signs of lung cancer.

July 24, 2012

DENVER--(BUSINESS WIRE)--The TriZetto Group, Inc., announced today it has engaged with BlueCross BlueShield of Tennessee as a strategic advisor and technology partner to collaborate...

July 24, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--New SEEDS supplier added to Premier’s equipment planning, procurement, installation and transition planning services portfolio

July 24, 2012

SOMERSET, N.J.--(BUSINESS WIRE)--Catalent announced it has commenced supply to Otsuka Pharmaceutical Co., Ltd. of Abilify® OD Tablets (orally disintegrating tablets (ODT)), which utilize Catalent’s Zydis® fast dissolve drug delivery technology....

July 24, 2012

HACKENSACK, N.J.--(BUSINESS WIRE)--ADMA Biologics, Inc. (ADMA), a late-stage biotechnology company focused on the development and commercialization of human plasma and plasma-derived therapeutics, today announced it has appointed Lawrence Guiheen...

July 24, 2012

ANN ARBOR, Mich.--(BUSINESS WIRE)--Right Brain Networks, a cloud-based application development and hosting company, offers clients faster performance and more control over their hosting investment with Online Tech’s HIPAA and SSAE 16 compliant...

July 24, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer Receives State of Connecticut Clinical Laboratory Licensure and CLIA Certificate of Registration for Global DNA Sequencing Services

July 24, 2012

NEW YORK--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE: FRX) (“Forest”) today announced that the Company has filed a presentation with the Securities and Exchange Commission (“SEC”) in connection with its Annual Meeting of Shareholders to be...

July 24, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Regenerative medicine company Histogenics Corporation, announced today the completion of a $49 million round of financing. Funds will be used to advance NeoCart for treatment of knee cartilage injury.

July 24, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that Lawrence Bloch, M.D., J.D., has joined Infinity as executive vice president, chief financial officer and chief business officer. In this role,...

July 24, 2012

OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (OTCBB: TBIO) today announced that National Government Services, the designated Medicare fiscal intermediary in Connecticut, has confirmed coverage for its proprietary Clopidogrel Genetic...

July 24, 2012

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Theorem Clinical Research has named Shannon Gordon as vice president of global project management.

July 24, 2012

CINCINNATI--(BUSINESS WIRE)--Camargo Pharmaceutical Services successfully completed five Food and Drug Administration (FDA) pre-IND meetings for 505(b)(2) products in the month of June.

July 24, 2012

WESTON, Mass.--(BUSINESS WIRE)--Second graph after the first series of bullets should read: The company also completed its previously ... (sted During the second quarter, the company also completed its previously ...). The corrected release reads...

July 24, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Repligen Corporation (NASDAQ:RGEN) today announced it will report financial results for the second quarter of 2012 before the NASDAQ Global Market opens on Thursday, August 2. The earnings press release will be...

July 24, 2012

NEW YORK--(BUSINESS WIRE)--The New York Genome Center (NYGC) and Edward J. Minskoff Equities, Inc. (EJME) are pleased to announce the execution of a 20-year lease for 170,000 square feet at 101 Avenue of the Americas (...

July 24, 2012

SAN JOSE, Calif.--(BUSINESS WIRE)--HTS laboratories continue to adopt new technologies and practices that are leading to more effective drug discovery approaches. For example, the directors at HTS laboratories see an increase in the importance of...

July 24, 2012

CUMBERLAND, R.I.--(BUSINESS WIRE)--Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain is pleased to announce the appointment of Gino Santini to its Board of...

July 24, 2012

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (NASDAQ: BRKR) announced today that based upon preliminary financial data the Company expects total second quarter 2012 revenue of approximately $420 million, compared to second quarter 2011...

July 24, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced favorable 52-week safety results and sustained efficacy from the extension phase of its randomized Phase 2b trial of ulodesine (BCX4208)...

July 24, 2012

DUBLIN--(BUSINESS WIRE)--ICON plc, ICON Clinical Research, Ciaran Murray, Brendan Brennan, ICON Quarterly Results

July 24, 2012

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it will host a conference call and live webcast to report its second quarter 2012 financial results on Tuesday, July 31 at 8:30 a.m. ET. To participate...

July 24, 2012

CINCINNATI--(BUSINESS WIRE)--Camargo Pharmaceutical Services successfully completed five Food and Drug Administration (FDA) pre-IND meetings for 505(b)(2) products , including two of India’s top 10 largest pharma companies.

July 23, 2012

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE:ELN) announced today that Pfizer has issued a top-line result in the first of four Bapineuzumab Phase 3 studies carried out by Pfizer and Janssen AI. The press release can be accessed on...

July 23, 2012

HACKENSACK, N.J.--(BUSINESS WIRE)--ADMA Biologics, Inc. (ADMA), a late-stage biotechnology company focused on the development and commercialization of human plasma and plasma-derived therapeutics, today announced it has appointed Dr. Mond as its...

July 23, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Prof. Victor Ambros, whose laboratory identified the first microRNA, joins Firefly BioWorks' Scientific Advisory Board

July 23, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today launched its real-time PCR reagent portfolio, including a novel, probe-based chemistry for gene expression analysis called NūPCR™. In addition to the NuPCR Reagents, Illumina...

July 23, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) announced today that the first subjects have been dosed in a Phase 1, randomized, double-blind, two-period crossover, food effect comparison study of XP23829 in healthy adults....

July 23, 2012

NEW YORK & BARCELONA, Spain--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE:FRX) and Almirall, S.A. (ALM.MC) announced today that the U.S. Food and Drug Administration (FDA) has approved Tudorza™ Pressair™ (aclidinium bromide inhalation...

July 23, 2012

NEW YORK--(BUSINESS WIRE)--WIRED and Robert Wood Johnson Foundation today announced that they are partnering to host the first-ever WIRED Health Conference: Living By Numbers, which will be held on October 15-16, 2012 at Le Parker Meriden in New...

July 23, 2012

NORTHWOOD, Ohio--(BUSINESS WIRE)--NAMSA, the world’s leading medical device research organization, has acquired The Integra Group, a preclinical and clinical research organization located near Minneapolis.

July 23, 2012

KNOXVILLE, Tenn.--(BUSINESS WIRE)--BioPet Vet Lab, has launched IntegriMEAT™, a DNA-source verified program aimed to produce an identification and tracking program for America’s livestock.

July 23, 2012

GENEVA & WASHINGTON & MONTREAL--(BUSINESS WIRE)--Launch of 2 Fields 2 Goal: Protecting the Integrity of Science and Sports campaign to stop doping in sports.

July 23, 2012

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/...

July 23, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--Nation’s largest bundled payment collaborative helping health systems succeed in public and private market arrangements

July 23, 2012

IRVINE, Calif.--(BUSINESS WIRE)--HALO Healthcare is developing biomarkers for early detection of breast cancer. The kit will use nipple aspirate fluid collected with the HALO Breast Test to detect breast cancer in women.

July 23, 2012

NEWTON, Mass.--(BUSINESS WIRE)--Galectin Therapeutics has received a notice of issuance from the USPTO for key methods of derivation and use for the Company’s carbohydrate-based galectin inhibitor compound in liver fibrosis.